Working Parties
The General Assembly comprises all full members
and meets at least once a year (The last EFPIA Statutory General Assembly took take place in Seville on 14 May 2009). As the sovereign power of the association, the General Assembly defines the association's general policy.
The Board comprises representatives of 11 full member companies and 11 full member associations elected for a period of two years. It carries out the tasks and duties determined by the General Assembly and ensures that these are implemented by the General Management.
A Bureau of 7 Board members is entrusted to give advance opinions on items placed on the Board agenda. Where sustained high-level attention is required on a critical issue, the Board may set up a Priority Action Team chaired by a CEO of a member company.
The Board adopts EFPIA's
and provides guidance for policy lines and recommendations elaborated by the 4 main Policy Committees:
- Economic and Social Policy Committee (ESPC)
- External Trade Policy Committee (ETPC)
- Scientific, Technical and Regulatory Policy Committee (STRPC)
- Intellectual Property Policy Committee (IPPC)
Ad hoc groups report to these Policy Committees.
EFPIA Board Delegates (Nominations 2008/2010)
President
Andrew Witty, GlaxoSmithKline (United Kingdom)
Vice-President
Chris Viehbacher, Sanofi-aventis (France)
Elmar Schnee, Merck Serono (Germany)
Member Company Delegates
Lucia Aleotti, Menarini (Italy)
Andreas Barner, Boehringer Ingelheim (Germany)
Olivier Bohuon, Abbott (USA)
David Brennan, AstraZeneca (UK, Sweden)
Bryce Carmine, Eli Lilly & Co. (USA)
Eric Cornut, Novartis (Switzerland)
Roch Doliveux, UCB (Belgium)
Andreas Fibig, Bayer Healthcare (Germany)
Ken Frazier, Merck Sharp & Dohme (USA)
Jorge Gallardo, Almirall (Spain)
Carlo Incerti, Genzyme (USA)
Joe Jimenez, Novartis (Switzerland)
Jaak Peeters, Johnson & Johnson (USA)
Ian Read, Pfizer (USA)
Lars Rebien Sorensen, Novo Nordisk (Denmark)
Ulf Wijnberg, H. Lundbeck (Danemark)
Member Association Delegates
João Almeida Lopes, Apifarma (Portugal)
Humberto Arnes, Farmaindustria (Spain)
Richard Barker, ABPI (UK)
Richard Bergström, LIF (Sweden)
Claudio Cavazza, Farmindustria (Italy)
Thomas B. Cueni, SSIC/Interpharma (Switzerland)
Michel Dutree, Nefarma (The Netherlands)
Ida Sofie Jensen, LIF (Denmark)
Philippe Lamoureux, LEEM (France)
Pawel Sztwiertnia, Infarma (Poland)
Cornelia Yzer, VFA (Germany)
General Management
Brian Ager, Director General
Marie-Claire Pickaert, Deputy Director General
Priority Actions Teams and leading groups
Heads of Europe Group
Chair - Eric Cornut, Novartis
Research Director Group
Chair - Prof. Jonathan Knowles, Hoffmann La Roche
Communication & Partnership PAT
Chair - Roch Doliveux, UCB
CEEC (Central and Eastern European Countries) Task Force
Chair - Robert Szymanski, AstraZeneca
Animal Welfare Task Force
Chair - Tim Hammond, AstraZeneca
Vice-Chair - Brian Ager, EFPIA
Informed Patient Task Force
Co-Chair - Paul Woods, AstraZeneca
Co-Chair - Fiona Brownlie, Sanofi-aventis
PAT Pharmaceutical Package
Chair - Brian Ager, EFPIA
Policy Committees
Economic and Social Policy Committee (ESPC)
Chair - Thomas B. Cueni, Interpharma
External Trade Policy Committee (ETPC)
Chair - Maggie Mees, AstraZeneca
Vice-Chair - Richard Saul, Wyeth
Scientific, Technical and Regulatory Policy Committee (STRPC)
Chair - Sue Forday, Eli Lilly
Vice-Chair - Jean Pierre Lehner, Sanofi-aventis
Intellectual Property Policy Committee (IPPC)
Chair - David Rosenberg, GlaxoSmithKline
Vice-Chair - Anne Nielsen, Bristol Myers Squibb
All technical issues are dealt with by ad hoc working groups reporting to these policy committees.
Bureau
Andrew Witty, GlaxoSmithKline (President)
Jean-François Dehecq, Sanofi-aventis (Vice-President)
Richard Barker, ABPI
Bill Burns, Hoffmann-La Roche
Jorge Gallardo, Laboratorios Almirall S.A.
Jaak Peeters, Johnson & Johnson
Stefan Oschmann, Merck, Sharp & Dohme
Specialised Groups
European Vaccine Manufacturers (EVM)
President - Didier Hoch, Sanofi Pasteur MSD
European Biopharmaceutical Enterprises (EBE)
President - Carlo Incerti, Genzyme
Accounts & Budgets Committee
Chairman - David Hill
|